Wound Management Technologies Inc Share Price Other OTC
Equities
US98211X1063
Pharmaceuticals
Sales 2024 * | 7.73Cr 644.68Cr | Sales 2025 * | 8.86Cr 738.92Cr | Capitalization | 24Cr 2.03TCr |
---|---|---|---|---|---|
Net income 2024 * | -60L -50Cr | Net income 2025 * | -10L -8.34Cr | EV / Sales 2024 * | 3.15 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.75 x |
P/E ratio 2024 * |
-35.7
x | P/E ratio 2025 * |
-257
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.54% |
Latest transcript on Wound Management Technologies Inc
Managers | Title | Age | Since |
---|---|---|---|
Michael McNeil
DFI | Director of Finance/CFO | 59 | 11/18/11 |
Chief Tech/Sci/R&D Officer | - | 01/23/01 | |
Chief Tech/Sci/R&D Officer | 39 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Tanzberger
BRD | Director/Board Member | 55 | 01/22/01 |
Roszell Mack
BRD | Director/Board Member | 57 | 01/22/01 |
Eric Major
BRD | Director/Board Member | 55 | 01/23/01 |
1st Jan change | Capi. | |
---|---|---|
+55.30% | 82TCr | |
+43.17% | 64TCr | |
-5.37% | 35TCr | |
+17.85% | 31TCr | |
+11.35% | 30TCr | |
+16.74% | 24TCr | |
+2.58% | 22TCr | |
+14.22% | 22TCr | |
+9.66% | 17TCr |